Gastric Inhibitory Polypeptide (3-42) (human)
Gastric Inhibitory Polypeptide (3-42) (human), the main physiological degradation product of gastric inhibitory polypeptide (GIP), is produced by proteolytic processing of GIP by dipeptidyl peptidase IV (DPP IV). It is a glucose-dependent insulinotropic polypeptide (GIP) receptor antagonist that regulates insulin secretion and GIP metabolism in vivo.
Supplier | BOC Sciences |
---|---|
Product # | BAT-014467 |
Pricing | Inquire |
Cas | 1802086-25-4 |
Molecular Weight | 4749.35 |
Molecular Formula | C214H324N58O63S |